A 4D-CBCT correction network based on contrastive learning for dose calculation in lung cancer
Nannan Cao1,2,3,4, Ziyi Wang1,2,3,4, Jiangyi Ding1,2,3,4
1Department of Radiotherapy, The Affiliated Changzhou NO.2 People's Hospital of Nanjing Medical University, Changzhou, 213003, China.
Radiation Oncology (London, England)
|February 9, 2024
Summary
A novel deep-learning network, contrastive learning-based cycle generative adversarial networks (CLCGAN), improves four-dimensional cone beam computed tomography (4D-CBCT) image quality and CT value accuracy for lung cancer patients. This advancement enables more precise dose calculations in radiation therapy.
Area of Science:
- Medical Imaging
- Artificial Intelligence in Medicine
- Radiation Oncology
Background:
- Four-dimensional cone beam computed tomography (4D-CBCT) is crucial for lung cancer radiotherapy but suffers from streak artifacts and inaccurate CT values.
- These image quality issues can compromise the accuracy of radiation dose calculations.
Purpose of the Study:
- To introduce a deep-learning network, contrastive learning-based cycle generative adversarial networks (CLCGAN), for artifact reduction and CT value correction in 4D-CBCT.
- To evaluate the impact of CLCGAN on image quality and dose calculation accuracy for lung cancer patients.
Main Methods:
- A CLCGAN model was trained using paired 4D-CBCT and 4D CT data from lung cancer patients.
- The model generated 4D synthetic CT (4D-sCT) images, which were quantitatively and qualitatively assessed against ground truth 4D CT.
- Dose distributions and calculations derived from 4D-CBCT and 4D-sCT were compared to 4D CT.
Main Results:
- CLCGAN significantly improved image quality metrics (SSIM, PSNR) of 4D-sCT compared to baseline methods.
- The network reduced absolute mean differences in CT values across various tissues (lungs, bones, soft tissues).
- Dose calculations using CLCGAN-corrected 4D-CBCT showed significant improvements, with reduced relative dose differences compared to standard 4D-CBCT.
Conclusions:
- CLCGAN effectively mitigates streak artifacts and corrects CT values in 4D-CBCT for lung cancer patients.
- The improved image quality and CT value accuracy facilitate more reliable dose calculations.
- CLCGAN-corrected 4D-CBCT shows potential for clinical use in lung cancer radiotherapy planning and delivery.


